Dr. Ashwani Kumar, Ex-Chief Manufacturing & Compliance Officer, Unichem Laboratories Limited, in an exclusive interview with India Pharma Outlook, shares his views on how the pharmaceutical industry manages cost efficiency while maintaining...
Ardena, a focused pharmaceutical Contract Development and Manufacturing Organization (CDMO) and bioanalytical Contract Research Organization (CRO) operating in Belgium, Spain, the Netherlands, and Sweden, has finalized its acquisition of Catalent...
Industry experts from the healthcare segment made their remarks post-budget 2025. The budget strengthens India's commitment to health innovation, inclusive growth and improved access to nutrition. The exemption of around 40 life-saving drugs from...
Jupiter Neurosciences Inc., a pharmaceutical company in the clinical stage, is developing JOTROL, a patented platform based on resveratrol, and has reached an agreement with Catalent Pharma Solutions LLC to produce JOTROL softgel capsules to...
Vanda Pharmaceuticals Inc. and AnaptysBio, Inc. announced an exclusive worldwide licensing agreement for the development and marketing of imsidolimab (IL-36R antagonist mAb), which has successfully finished two registration-supporting global Phase...
Sudarshan Pharma Industries revealed the authorization of Rs 188 Cr in capital raising via 4.3 Cr convertible warrants. The firm acknowledged the contract established between the Monitoring agency and the enterprise on January 29, 2025, and...
The Union Budget 2025 has proposed a 9.78 per cent rise in funding for healthcare for the fiscal year 2025-26, amounting to Rs. 99,858.56 crore in contrast to Rs. The ministry of health and family welfare states that the amount will be 90,958.63...
After a successful edition of the maiden award ceremony in 2024, Eminence is thrilled to announce the Pharma Quality Excellence Awards 2025, taking place on April 25th, 2025, in conjunction with the 5th Annual Pharma GMP and Quality Management 2025
The pharmaceutical industry is undergoing rapid transformation, with an increasing focus on quality, compliance, and innovation in manufacturing processes. In this context, Eminence Business Media has announced 5th Annual Pharma GMP and Quality Manag
Bajaj Healthcare announced that it has obtained approval from the Drug Controller General of India (DCGI) to produce both the API and drug formulation of Pimavanserin. Pimavanserin is an atypical antipsychotic utilized to treat hallucinations and...
, CDSCO.jpg)
